Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net income (loss) from operations	$ (1,920,793)	$ 1,258,479
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	4,625	8,876
Stock-based compensation expense	58,974
Changes in assets and liabilities:
Prepaid expenses and other current assets	178,226	592,511
Other assets	6,228
Amortization of operating lease right-of-use asset	31,610	138,236
Accounts payable	(407,009)	11,079
Operating lease liabilities	(33,605)	(146,078)
Accrued expenses and other current liabilities	68,925	14,124
Net cash provided by (used in) operating activities	(2,012,819)	1,877,227
Cash flows from financing activities
Preferred stock dividend		(68,809)
Purchase of preferred investment option		(250,000)
Net cash used in financing activities		(318,809)
Net increase (decrease) in cash and cash equivalents	(2,012,819)	1,558,418
Cash and cash equivalents at beginning of period	2,070,075	1,374,992
Cash and cash equivalents at end of period	57,256	2,933,410
Supplemental disclosure of Cash Flow Information:
Conversion of Series C 10% Convertible Preferred Stock to Common Stock		$ 1,343,684